No retraction, correction or concern found when last checked on Oct 19, 2026.
The fluorination effect of fluoroamphiphiles in cytosolic protein delivery
Zhenjing Zhang, Wanwan Shen, Jing Ling and 3 more
Nature Communications · 2018 · CC BY
doi:10.1038/s41467-018-03779-8
Abstract
Direct delivery of proteins into cells avoids many drawbacks of gene delivery, and thus has emerging applications in biotherapy. However, it remains a challenging task owing to limited charges and relatively large size of proteins. Here, we report an efficient protein delivery system via the co-assembly of fluoroamphiphiles and proteins into nanoparticles. Fluorous substituents on the amphiphiles play essential roles in the formation of uniform nanoparticles, avoiding protein denaturation, efficient endocytosis, and maintaining low cytotoxicity. Structure-activity relationship studies reveal that longer fluorous chain length and higher fluorination degree contribute to more efficient protein delivery, but excess fluorophilicity on the polymer leads to the pre-assembly of fluoroamphiphiles into stable vesicles, and thus failed protein encapsulation and cytosolic delivery. This study highlights the advantage of fluoroamphiphiles over other existing strategies for intracellular protein delivery.
Full text
From PubMed Central, U.S. National Library of Medicine, as current on Oct 19, 2026. Paragraph numbers are ours, so an answer can point at one.
Introduction
Numerous human diseases arise from mutations or other abnormalities on proteins owing to their essential functions in enzyme catalysis, signal transduction, gene regulation, maintaining the delicate balance between cell survival, and programmed cell death, etc,. During the past decades, protein biotherapeutics including peptide hormones, growth factors, cytokines, and monoclonal antibodies have been discovered or engineered to treat these diseases. Protein therapeutics offer several advantages over small molecule drugs, such as higher specificity, limited adverse effects, and faster clinical development. However, proteins are generally membrane-impermeable due to their relatively large size, hydrophilicity and limited positive charges, which make them difficult to reach the intracellular targets. Therefore, most current protein drugs are developed based on extracellular targets. To expand the family of protein therapeutics, it is of great importance to develop efficient strategies for cytosolic protein delivery,.
Cytosolic protein delivery is challenging since the vehicle should efficiently bind the protein, protect it against degradation, initiate efficient internalization, trigger endosomal disruption, and release the proteins into cytosol. In retrospect, the most studied approach has been fusing proteins with protein transduction domains (PTD)–. However, PTD-based strategies displayed a certain number of limitations that most of them require chemical modification of target proteins. The covalent conjugation of PTD to cargo proteins might be involved with reduced bioactivity and safety concerns. Besides, many other delivery systems have been developed based on liposomes,, peptides, polymers,, and inorganic nanoparticles,. These approaches still possess some limitations such as the need of protein modification, complicated synthesis, and limited transduction efficacy.
Recently, fluoroamphiphiles such as fluorinated dendrimers and polyethylenimines (PEIs) were reported to have promising features like no other non-viral carriers–. These materials encountered multiple hurdles during gene delivery. In addition, the fluoroamphiphiles possess excellent self-assembly property,–. Combining these features together, it is rational to develop fluoroamphiphiles for cytosolic protein delivery. Proteins could be fabricated into nanoparticles via the co-assembly of fluoroamphiphiles and proteins. The fluorocarbons could improve the affinity of polymers to cell membranes and facilitate the endocytosis–. In addition, the fluorous ligands are generally lipophobic and bioinert, and this property is beneficial for the avoidance of protein denaturation and the retention of protein bioactivity. Finally, the replacement of hydrocarbons on traditional amphiphiles with fluoroalkyls is responsive for less cytotoxicity and hemolytic activity.
As a proof-of-concept, we synthesize a small library of fluoroamphiphiles by grafting fluoroalkyls to branched PEI for cytosolic protein delivery. Traditional amphiphiles such as alkane- and cycloalkane-grafted PEIs are also included to reveal the effect of fluorination and highlight the advantages of fluoroamphiphiles over other existing amphiphilic materials. Model proteins such as bovine serum albumin (BSA), β-galactosidase (β-Gal), saporin, and peptide (GRKKRRQRRREKIKRPRSSNAETL) with different molecular sizes and charge properties (BSA and β-Gal are negatively charged, saporin and the peptide are positively charged) are employed to test the efficacy of developed fluoroamphiphiles. We demonstrate that the discovered fluoroamphiphiles efficiently deliver unmodified proteins into cells without inducing cytotoxicity.
Screening of efficient fluoroamphiphiles
Branched PEI was grafted with fluoroalkanes (F1-F4), alkanes (A1-A4), and cycloalkanes (C1-C4) via amine-epoxide or amine-isocyanate reactions (Fig. 1),. Each ligand was coupled to PEI at four conjugation degrees. Take F3 for example, the average numbers of conjugated F3 per PEI were 28, 54, 76, and 102, respectively, and the materials were termed F3-1, F3-2, F3-3, and F3-4, respectively. Unmodified PEI and a commercial reagent PulsinTM were used as negative and positive controls, respectively. A total number of 50 materials were used as the screening pool to discover efficient materials (Supplementary Table 1).
We first investigated efficacies of the 50 candidates in the library using a fluorescein isothiocyanate labeled BSA (BSA-FITC, 0.3 μM). The highest fluorescence intensity for each material was shown in Supplementary Fig. 1 and Table 1. The transfected cells at optimal condition for each material were also treated with trypan blue to quench the BSA-FITC physically adsorbed on cell membrane. The fluorescence intensity of cells after trypan blue quenching was shown in Fig. 1c.
As shown in Fig. 1c, 11 materials (7 fluoroalkane-grafted and 4 alkane-grafted materials) showed superior efficacies to the positive control PulsinTM. The top two performing fluoroamphiphiles F4-1 and F3-3 are much more efficient than the others in the library. When F4-1 and F3-3 mediated BSA-FITC delivery was carried out at 4 °C, or added with sodium azide, fluorescence from the cells decreased significantly (Supplementary Fig. 2), suggesting endocytosis as the primary mechanism of internalization. The endocytosis of F4-1 and F3-3 complexes is mediated by both macropinocytosis- and caveolae-dependent pathways (Supplementary Fig. 3). The cells treated with F4-1/F3-3 complexes exhibited strong and evenly distributed fluorescence in the cytosol after 1 h incubation, and the internalized proteins were not co-localized with acidic organelles (Supplementary Fig. 4). These results proved that F4-1 and F3-3 are capable of rapidly transporting proteins into cells and releasing cargos in the cytosol.
Fluorination effect of fluoroamphiphiles
Since the efficacies of F4-1 and F3-3 are much superior to the non-fluorinated analogs. We further investigated the effect of fluorination on cytosolic protein delivery. It was reported that the contribution of a CF2 group to hydrophobicity was about 1.5 times that of a CH2 group, and thus the hydrophobicity of F3 and F4 could be roughly equivalent to that of A3 and A4, respectively. In this case, A4-1 and A3-3 in the library can be used as non-fluorinated controls for F4-1 and F3-3, respectively. As revealed by the confocal images in Fig. 2a, BSA-FITC delivered by F4-1 or F3-3 were mainly dispersed in cytosol, while those by A4-1 and A3-3 were observed in green dots and seemed to be absorbed on cell membrane. The fluorescence quenching experiment in Fig. 2b further confirmed this hypothesis, nearly 90% fluorescence intensity from F4-1/F3-3 complexes was retained after the addition of trypan blue, a cell membrane-impermeable fluorescence quencher, while the values were less than 40% for non-fluorinated controls. Even when the transfection time for non-fluorinated polymers was increased from 4 to 24 h, the observed fluorescence was scarcely increased, and only green dots were observed on cell surface (Supplementary Figs. 5 and 6). Both non-fluorinated complexes are internalized via macropinocytosis- and caveolae-dependent pathways (Supplementary Fig. 7). Fluorocarbons are both hydrophobic and lipophobic, and the mixing of fluorocarbons and hydrocarbons is highly non-ideal. Therefore, the fluoroamphiphiles and phospholipids have limited miscibility, which ensures efficient cell internalization of fluoroamphiphiles,. In comparison, the non-fluorinated controls are consisted of hydrocarbon chains, which are easily fused with the membranes after cell attachment. The fusion of phospholipids and hydrogenated amphiphiles will lead to early release of proteins and failed cytosolic delivery (Fig. 2c). It is worth noting that all the cycloalkane-based amphiphiles showed poor efficacies, and the materials were even less efficient than alkane-based ones. BSA-FITC delivered by cycloalkane amphiphiles, such as C4-2 also showed significant membrane absorption (Supplementary Fig. 8). These results suggested the beneficial effect of fluorination in cytosolic protein delivery.
We further compared the behaviors of fluoroamphiphiles and non-fluorinated controls in the aspects of nanocomplex formation, protein denaturation, cellular uptake and cytotoxicity. As shown in Fig. 3a, fluoroamphiphiles and BSA formed uniform nanoparticles (~200 nm) with a low particle dispersion index (PDI) around 0.1, while the non-fluorinated A4-1 and A3-3 tend to form anomalous aggregations (PDI > 0.5). This result can be explained by the strong surface activity of fluoroamphiphiles compared with non-fluorinated ones. It was reported that the incremental change in the free energy of adsorption for the transfer of a CF2 group from water to the air/water surface is almost twice that of a CH2 group (−5.1 vs. −2.6 kJ/mol). The strong surface activity of fluoroamphiphiles dramatically increases the tendency to assemble in water,,,. In comparison, hydrogenated amphiphiles possess relatively lower surface activity, and the lipophilic chains also have high affinity with proteins via hydrophobic interactions, which drives the formation of large aggregates. The non-specific hydrophobic interactions between alkanes and proteins may denature the bound proteins. Circular dichroism results in Fig. 3b confirmed this hypothesis. BSA complexed with A4-1 and A3-3 showed significant changes in protein secondary structures, while those bound by fluoroamphiphiles relatively approached native BSA. The fluoroalkyl chains are relatively bioinert and usually used for antifouling purposes–, therefore the F4-1 and F3-3 nanocomplexes showed limited protein denaturation. The partially denatured BSA in the A4-1 or A3-3 complexes also explained the long-term absorptions of BSA-FITC on cell membranes in Fig. 2a and Supplementary Fig. 5.
Next, we tested the membrane permeability of fluoroamphiphiles in the absence of proteins. As shown in Fig. 3c, fluoroamphiphiles labeled with FITC showed much higher internalization than non-fluorinated controls, which is in accordance with results observed on fluorinated dendrimers,,. Fluoroalkyl chains have a strong tendency to adsorb on cell membranes due to exceedingly low fluoroalkyl-water interactions, and favorable cell adhesion is beneficial for efficient cellular uptake. In addition, the limited miscibility between fluoroalkyl and phospholipids can minimize the fusion of amphiphiles with cell membranes during endocytosis, which is a dominant feature for hydrogenated amphiphiles. Fusion of hydrogenated amphiphiles not only leads to long-term retention of materials on cell membrane, but may also cause membrane disruption and cytotoxicity. Therefore, the fluoroamphiphiles and their complexes showed much lower toxicity than the hydrogenated controls (Fig. 3d and Supplementary Fig. 9).
Structure-activity relationships of fluoroamphiphiles
We further investigated the structure-activity relationships of fluoroamphiphiles in cytosolic protein delivery. As shown in Fig. 4a, the fluoroamphiphiles with longer chains or higher grafting degrees generally exhibited higher efficacies. However, this rule is invalid for F3-4, F4-3, and F4-4. These fluoroamphiphiles possess relatively long fluoroalkyl chains and high fluorination degrees, but showed extremely low delivery efficacy. It is known that longer fluoroalkyl chains and higher fluorination degrees lead to higher gene delivery. Considering differences between protein and gene delivery, we hypothesized that the low efficacies of F3-4, F4-3, and F4-4 are attributed to poor protein encapsulation. In this case, we systemically investigated the self-assembly behaviors of fluoroamphiphiles. As shown in Fig. 4b and Supplementary Fig. 10, all the fluoroamphiphiles except F3-4, F4-3, and F4-4 failed to assemble into nanoparticles in the absence of BSA at concentrations up to 15 μM, while F3-4, F4-3, and F4-4 could form nanoparticles or vesicles (PDI < 0.3) even at 0.3 μM (Supplementary Fig. 11). As previously reported, a decrease of hydrophilic to hydrophobic segment ratio in amphiphiles lead to the change of assembled nanostructures from spherical to cylindrical micelles and finally to vesicles. The assembly of fluoroamphiphiles usually forms internal Teflon-like hydrophobic and lipophobic films that increase the stability of assembles and reduces its permeability to hydrophilic molecules,. This process may hinder the encapsulation of protein within the assembled nanostructures, and thus proteins only bind on the surface of nanoassembles via electrostatic interactions. As a result, the complexation of these fluoroamphiphiles with BSA, an anionic protein at pH 7.4, leads to the decrease of zeta-potential of formed nanoparticles. We further labeled BSA with platinum (Pt) nanoparticles. The TEM results in Fig. 4c confirmed that the encapsulation of Pt-labeled BSA was hindered in F3-4 and F4-4 nanoassembles. On the other hand, F3-3 and F4-1 co-assembled with BSA to form nanocomplexes (PDI < 0.3). The binding of anionic region of BSA to cationic PEI facilitate the assembly process. The element mapping results in Supplementary Fig. 12 showed that Pt nanoparticles were homogeneously distributed in the F4-1/F3-3 nanocomplexes. The failed protein encapsulation by F3-4 and F4-4 is further confirmed by a BCA assay. As shown in Fig. 4d, nearly 100% BSA complexed with F3-4 and F4-4 could be detected by the BCA assay, while 70% proteins within the F4-1 and F3-3 complexes could not be measured, which is an indication of protein encapsulation. These results together confirmed that excess fluorophilicity on the polymer leads to pre-assembly of fluoroamphiphiles and failed protein encapsulation.
Robustness of fluoroamphiphiles
We further tested the efficacies of F4-1 and F3-3 on other cell lines. As shown in Fig. 5a, b, both materials successfully delivered BSA-FITC into NIH3T3 and HEK293 cells. In addition, fluoroamphiphile-mediated BSA-FITC delivery is much more efficient than TAT-conjugated proteins (Supplementary Fig. 13). The materials are also efficient in the delivery of β-Gal, saporin, and a peptide (GRKKRRQRRREKIKRPRSSNAETL-FITC). As shown in Fig. 5c–f, F4-1 and F3-3 showed impressive efficacies in the delivery of these biomolecules. More importantly, the bioactivity of proteins such as β-Gal delivered by the fluoroamphiphiles could be maintained (Fig. 5f and Supplementary Fig. 14). These results confirmed that F4-1 and F3-3 can be used as vehicles for the delivery of various proteins without the need of chemical modification.
Discussion
In the library, the fluoroalkanes F1, F2, F3, and F4 have 7, 8, 9, and 13 fluorine atoms, respectively. The striking difference between F1/F2- and F3-based fluoroamphiphiles in protein delivery can be explained by an additive fluorination effect. A single or two fluorine differences in the structure may have significant influence on its physicochemical properties and transduction efficacy. Therefore, the length of fluoroalkyl chain and the fluorination degree on a specific fluoroamphiphile need to be optimized before use. Structure-activity relationship studies reveal that a balance in fluorophilicity is beneficial for efficient protein delivery. Pre-assembly of the fluoroamphiphiles before protein encapsulation should be avoided. The lead fluoroamphiphiles F4-1 and F3-3 discovered in the library successfully delivered various proteins with distinct isoelectric points and molecular weights into the cytosol. The fluoroamphiphiles showed robustness of nanoparticle formation with BSA, β-gal, and saporin at different weight ratios (Supplementary Table 2). Though saporin is a positively charged protein at physiological conditions, the binding of anionic region on saporin to the cationic fluoroamphiphiles may help the formation of nanocomplexes. The nanocomplexes formed at different protein to amphiphile weight ratios were tested on cells to confirm the effectiveness. The fluorescence from HeLa cells increased in proportion to protein concentration in the range of 2–20 μg/mL, and the internalization is saturated at higher protein concentrations (Supplementary Fig. 15), suggesting dose-dependent protein delivery. Though fluorinated substances were listed as persistent and bioaccumulative materials, the concentrations of fluoroamphiphiles in cytosolic protein delivery are minute, and further design of biodegradable fluoroamphiphiles may resolve the bioaccumulation issues for in vivo protein delivery.
In conclusion, we found the fluorination effect of polymers in cytosolic protein delivery. The fluoroamphiphiles show advantages in several aspects including improved protein encapsulation, avoiding protein denaturation, facilitated cellular uptake, and limited material toxicity in comparison with non-fluorinated materials. The fluoroamphiphiles allow the delivery of proteins into cells without the need of protein modification.
Intracellular protein delivery
BSA-FITC (4 μg) was mixed with the amphiphiles at different material to protein weight ratios. The yielding nanocomplexes were diluted with 50 μL serum-free media and incubated at room temperature for 30 min. Then the complexes were replenished with 150 μL serum-free media and added to the cells. After 4 h, the media were removed and the cells were washed with PBS and analyzed by flow cytometry (BD FACSCalibur, San Jose) and laser scanning confocal microscope (LSCM, Leica SP5, Germany). In a separate study, trypan blue (0.2 mg/mL) was added to the transfected cells before flow cytometry measurement. PulsinTM was used according to the manufacture’s protocol (4 μL reagent for each well). For other proteins, 5 μg β-Gal or 1 μg peptide were complexed with 2 μg F4-1 or 2.5 μg F3-3, respectively. The transfection procedure was the same as described above, and the cells were observed by fluorescence microscope (Olympus, Japan).
Materials and other methods are available in Supplementary Methods.
Data availability
The data supporting the findings in this study are available within the article and its supplementary information files. All data are available from the authors upon reasonable request.
References 59
- 1.
Zelikin AN, Ehrhardt C, Healy AM. Materials and methods for delivery of biological drugs. Nat. Chem. 2016;8:997-1007.
Not in our library10.1038/nchem.2629
- 2.
Mitragotri S, Burke PA, Langer R. Overcoming the challenges in administering biopharmaceuticals: formulation and delivery strategies. Nat. Rev. Drug. Discov. 2014;13:655-672.
Not in our library10.1038/nrd4363
- 3.
Zuris JA, et al. Cationic lipid-mediated delivery of proteins enables efficient protein-based genome editing in vitro and in vivo. Nat. Biotechnol. 2015;33:73-80.
Not in our library10.1038/nbt.3081
- 4.
Leader B, Baca QJ, Golan DE. Protein therapeutics: a summary and pharmacological classification. Nat. Rev. Drug. Discov. 2008;7:21-39.
Not in our library10.1038/nrd2399
- 5.
Postupalenko V, et al. Protein delivery system containing a nickel-immobilized polymer for multimerization of affinity-purified His-tagged proteins enhances cytosolic transfer. Angew. Chem. Int. Ed. 2015;54:10583-10586.
Not in our library10.1002/anie.201505437
- 6.
Akishiba M, et al. Cytosolic antibody delivery by lipid-sensitive endosomolytic peptide. Nat. Chem. 2017;9:751-761.
Not in our library10.1038/nchem.2779
- 7.
Lee K, et al. In vivo delivery of transcription factors with multifunctional oligonucleotides. Nat. Mater. 2015;14:701-706.
Not in our library10.1038/nmat4269
- 8.
Chang H, et al. Rational design of a polymer with robust efficacy for intracellular protein and peptide delivery. Nano. Lett. 2017;17:1678-1684.
Not in our library10.1021/acs.nanolett.6b04955
- 9.
Dixon JE, et al. Highly efficient delivery of functional cargoes by the synergistic effect of GAG binding motifs and cell-penetrating peptides. Proc. Natl Acad. Sci. USA. 2016;113:E291-E299.
Not in our library10.1073/pnas.1518634113
- 10.
Schwarze SR, Ho A, Vocero-Akbani A, Dowdy SF. In vivo protein transduction: delivery of a biologically active protein into the mouse. Science. 1999;285:1569-1572.
Not in our library10.1126/science.285.5433.1569
- 11.
Nischan N, et al. Covalent attachment of cyclic TAT peptides to GFP results in protein delivery into live cells with immediate bioavailability. Angew. Chem. Int. Ed. 2015;54:1950-1953.
Not in our library10.1002/anie.201410006
- 12.
June RK, Gogoi K, Eguchi A, Cui XS, Dowdy SF. Synthesis of a pH-sensitive nitrilotriacetic linker to peptide transduction domains to enable intracellular delivery of histidine imidazole ring-containing macromolecules. J. Am. Chem. Soc. 2010;132:10680-10682.
Not in our library10.1021/ja1040418
- 13.
Fu J, Yu C, Li L, Yao SQ. Intracellular delivery of functional proteins and native drugs by cell-penetrating poly(disulfide)s. J. Am. Chem. Soc. 2015;137:12153-12160.
Not in our library10.1021/jacs.5b08130
- 14.
Wang M, Alberti K, Sun S, Arellano CL, Xu Q. Combinatorially designed lipid-like nanoparticles for intracellular delivery of cytotoxic protein for cancer therapy. Angew. Chem. Int. Ed. 2014;53:2893-2898.
Not in our library10.1002/anie.201311245
- 15.
Wang M, Sun S, Neufeld CI, Perez-Ramirez B, Xu Q. Reactive oxygen species-responsive protein modification and its intracellular delivery for targeted cancer therapy. Angew. Chem. Int. Ed. 2014;53:13444-13448.
Not in our library10.1002/anie.201407234
- 16.
Motion JP, Nguyen J, Szoka FC. Phosphatase-triggered fusogenic liposomes for cytoplasmic delivery of cell-impermeable compounds. Angew. Chem. Int. Ed. 2012;51:9047-9051.
Not in our library10.1002/anie.201204198
- 17.
Ng DY, et al. Constructing hybrid protein zymogens through protective dendritic assembly. Angew. Chem. Int. Ed. 2014;53:324-328.
Not in our library10.1002/anie.201308533
- 18.
Bachelder EM, Beaudette TT, Broaders KE, Dashe J, Frechet JM. Acetal-derivatized dextran: an acid-responsive biodegradable material for therapeutic applications. J. Am. Chem. Soc. 2008;130:10494-10495.
Not in our library10.1021/ja803947s
- 19.
Yang Y, et al. Multi-shelled dendritic mesoporous organosilica hollow spheres: roles of composition and architecture in cancer immunotherapy. Angew. Chem. Int. Ed. 2017;56:8446-8450.
Not in our library10.1002/anie.201701550
- 20.
Mout R, et al. General strategy for direct cytosolic protein delivery via protein-nanoparticle co-engineering. ACS Nano. 2017;11:6416-6421.
Not in our library10.1021/acsnano.7b02884
- 21.
Wang M, Liu H, Li L, Cheng Y. A fluorinated dendrimer achieves excellent gene transfection efficacy at extremely low nitrogen to phosphorus ratios. Nat. Commun. 2014;5:3053.
Not in our library10.1038/ncomms4053
- 22.
Wang H, et al. Self-assembled fluorodendrimers combine the features of lipid and polymeric vectors in gene delivery. Angew. Chem. Int. Ed. 2015;54:11647-11651.
Not in our library10.1002/anie.201501461
- 23.
Liu H, Wang Y, Wang M, Xiao J, Cheng Y. Fluorinated poly(propylenimine) dendrimers as gene vectors. Biomaterials. 2014;35:5407-5413.
Not in our library10.1016/j.biomaterials.2014.03.040
- 24.
Wang M, Cheng Y. The effect of fluorination on the transfection efficacy of surface-engineered dendrimers. Biomaterials. 2014;35:6603-6613.
Not in our library10.1016/j.biomaterials.2014.04.065
- 25.
Tambe V, et al. Surface engineered dendrimers in siRNA delivery and gene silencing. Curr. Pharm. Des. 2017;16:2952-2975.
Not in our library10.2174/1381612823666170314104619
- 26.
Xiao Q, et al. Janus dendrimersomes coassembled from fluorinated, hydrogenated, and hybrid Janus dendrimers as models for cell fusion and fission. Proc. Natl Acad. Sci. USA. 2017;114:E7045-E7053.
Not in our library10.1073/pnas.1708380114
- 27.
Xiao Q, et al. Self-sorting and coassembly of fluorinated, hydrogenated, and hybrid Janus dendrimers into dendrimersomes. J. Am. Chem. Soc. 2016;138:12655-12663.
Not in our library10.1021/jacs.6b08069
- 28.
Brown GO, Bergquist C, Ferm P, Wooley KL. Unusual, promoted release of guests from amphiphilic cross-linked polymer networks. J. Am. Chem. Soc. 2005;127:11238-11239.
Not in our library10.1021/ja0534405
- 29.
Du W, et al. Amphiphilic hyperbranched fluoropolymers as nanoscopic 19F magnetic resonance imaging agent assemblies. Biomacromolecules. 2008;9:2826-2833.
Not in our library10.1021/bm800595b
- 30.
Wang LH, Wu DC, Xu HX, You YZ. High DNA-binding affinity and gene-transfection efficacy of bioreducible cationic nanomicelles with a fluorinated core. Angew. Chem. Int. Ed. 2016;55:755-759.
Not in our library10.1002/anie.201508695
- 31.
Wang H, Hu J, Cai X, Xiao J, Cheng Y. Self-assembled fluorodendrimers in the co-delivery of fluorinated drugs and therapeutic genes. Polym. Chem. 2016;7:2319-2322.
Not in our library10.1039/c6py00153j
- 32.
Smart BE. Fluorine substituent effects (on bioactivity). J. Fluor. Chem. 2001;109:3-11.
Not in our library10.1016/s0022-1139(01)00375-x
- 33.
Riess JG. Highly fluorinated amphiphilic molecules and self-assemblies with biomedical potential. Curr. Opin. Colloid Interface Sci. 2009;14:294-304.
Not in our library10.1016/j.cocis.2009.05.008
- 34.
Santaella C, et al. Polymorphic phase behavior of perfluoroalkylated phosphatidylcholines. Biochim. Biophys. Acta-Biomembr. 1994;1190:25-39.
Not in our library10.1016/0005-2736(94)90031-0
- 35.
Santaella C, Vierling P, Riess J. New perfluoroalkylated phospholipids as injectable surfactants: synthesis, preliminary physicochemical and biocompatibility data. New. J. Chem. 1991;15:685-692.
Not in our library
- 36.
Shen W, Liu H, Ling-hu Y, Wang H, Cheng Y. Enhanced siRNA delivery of a cyclododecylated dendrimer compared to its linear derivative. J. Mater. Chem. B. 2016;4:5654-5658.
Not in our library10.1039/c6tb01218c
- 37.
Shen W, et al. Screening of efficient polymers for siRNA delivery in a library of hydrophobically modified polyethyleneimines. J. Mater. Chem. B. 2016;4:6468-6474.
Not in our library10.1039/c6tb01929c
- 38.
Nuutila J, Lilius EM. Flow cytometric quantitative determination of ingestion by phagocytes needs the distinguishing of overlapping populations of binding and ingesting cells. Cytom. Part A. 2005;65A:93-102.
Not in our library10.1002/cyto.a.20139
- 39.
Kasuya MCZ, Nakano S, Katayama R, Hatanaka K. Evaluation of the hydrophobicity of perfluoroalkyl chains in amphiphilic compounds that are incorporated into cell membrane. J. Fluor. Chem. 2011;132:202-206.
Not in our library10.1016/j.jfluchem.2011.01.004
- 40.
Krafft MP. Fluorocarbons and fluorinated amphiphiles in drug delivery and biomedical research. Adv. Drug. Deliv. Rev. 2001;47:209-228.
Not in our library10.1016/s0169-409x(01)00107-7
- 41.
Yoder NC, et al. Nanoscale patterning in mixed fluorocarbon-hydrocarbon phospholipid bilayers. J. Am. Chem. Soc. 2007;129:9037-9043.
Not in our library10.1021/ja070950l
- 42.
Dafik L, Kalsani V, Leung AK, Kumar K. Fluorinated lipid constructs permit facile passage of molecular cargo into living cells. J. Am. Chem. Soc. 2009;131:12091-12093.
Not in our library10.1021/ja902777d
- 43.
Guan Z, Wang L, Lin J. Interaction pathways between plasma membrane and block copolymer micelles. Biomacromolecules. 2017;18:797-807.
Not in our library10.1021/acs.biomac.6b01674
- 44.
Mukerjee P, Handa T. Adsorption of fluorocarbon and hydrocarbon surfactants to air-water, hexane-water and perfluorohexane-water interfaces. Relative affinities and fluorocarbon-hydrocarbon nonideality effects. J. Phys. Chem. 1981;85:2298-2303.
Not in our library10.1021/j150615a032
- 45.
Tomalia DA. Supramolecular chemistry: fluorine makes a difference. Nat. Mater. 2003;2:711-712.
Not in our library10.1038/nmat1004
- 46.
Imbesi PM, et al. Noradrenaline-functionalized hyperbranched fluoropolymer-poly(ethylene glycol) cross-linked networks as dual-mode, anti-biofouling coatings. ACS Nano. 2012;6:1503-1512.
Not in our library10.1021/nn204431m
- 47.
Pollack KA, Imbesi PM, Raymond JE, Wooley KL. Hyperbranched fluoropolymer-polydimethylsiloxane-poly(ethylene glycol) cross-linked terpolymer networks designed for marine and biomedical applications: heterogeneous nontoxic antibiofouling surfaces. ACS Appl. Mater. Interfaces. 2014;6:19265-19274.
Not in our library10.1021/am505296n
- 48.
Zigmond JS, Letteri RA, Wooley KL. Amphiphilic cross-linked liquid crystalline fluoropolymer-poly(ethylene glycol) coatings for application in challenging conditions: comparative study between different liquid crystalline comonomers and polymer architectures. ACS Appl. Mater. Interfaces. 2016;8:33386-33393.
Not in our library10.1021/acsami.6b11112
- 49.
Gudipati CS, Finlay JA, Callow JA, Callow ME, Wooley KL. The antifouling and fouling-release performance of hyperbranched fluoropolymer (HBFP)-poly(ethylene glycol) (PEG) composite coatings evaluated by adsorption of biomacromolecules and the green fouling alga Ulva. Langmuir. 2005;21:3044-3053.
Not in our library10.1021/la048015o
- 50.
van der Goot FG, Lakey JH, Pattus F. The molten globule intermediate for protein insertion or translocation through membranes. Trends Cell Biol. 1992;2:343-348.
Not in our library10.1016/0962-8924(92)90184-o
- 51.
Wang M, Cheng Y. Structure-activity relationships of fluorinated dendrimers in DNA and siRNA delivery. Acta Biomater. 2016;46:204-210.
Not in our library10.1016/j.actbio.2016.09.023
- 52.
He B, Wang Y, Shao N, Chang H, Cheng Y. Polymers modified with double-tailed fluorous compounds for efficient DNA and siRNA delivery. Acta Biomater. 2015;22:111-119.
Not in our library10.1016/j.actbio.2015.04.037
- 53.
Krafft MP, Riess JG. Highly fluorinated amphiphiles and colloidal systems, and their applications in the biomedical field. A contribution. Biochimie. 1998;80:489-514.
Not in our library10.1016/s0300-9084(00)80016-4
- 54.
Liu Z, Zhang Z, Zhou C, Jiao Y. Hydrophobic modifications of cationic polymers for gene delivery. Prog. Polym. Sci. 2010;35:1144-1162.
Not in our library10.1016/j.progpolymsci.2010.04.007
- 55.
Cheng Y. Fluorinated polymers in gene delivery. Acta Polym. Sin. 2017;8:1234-1245.
Not in our library
- 56.
Chu Y, et al. Rational controlled morphological transitions in the self-assembled multi-headed giant surfactants in solution. Chem. Commun. 2016;52:8687-8690.
Not in our library10.1039/c6cc04567g
- 57.
Wang C, et al. Dynamic modulation of enzyme activity by near-infrared light. Angew. Chem. Int. Ed. 2017;56:6767-6772.
Not in our library10.1002/anie.201700968
- 58.
Stirpe F, et al. Ribosome-inactivating proteins from the seeds of Saponaria officinalis L. (soapwort), of Agrostemma githago L. (corn cockle) and of Asparagus officinalis L. (asparagus), and from the latex of Hura crepitans L. (sandbox tree). Biochem. J. 1983;216:617-625.
Not in our library10.1042/bj2160617
- 59.
Krafft MP, Riess JG. Per- and polyfluorinated substances (PFASs): environmental challenges. Curr. Opin. Colloid Interface Sci. 2015;20:192-212.
Not in our library10.1016/j.cocis.2015.07.004
Cited by papers we hold 2
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.